Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1955 1
1956 6
1957 7
1959 1
1960 2
1961 3
1962 1
1963 2
1964 1
1971 1
1972 2
1975 1
1976 3
1977 1
1978 1
1980 2
1981 2
1982 1
1983 3
1984 2
1985 3
1986 1
1987 2
1988 3
1990 2
1991 2
1992 10
1993 6
1994 9
1995 20
1996 25
1997 22
1998 32
1999 17
2000 22
2001 26
2002 15
2003 8
2004 8
2005 11
2006 17
2007 9
2008 12
2009 11
2010 13
2011 13
2012 15
2013 14
2014 18
2015 19
2016 31
2017 15
2018 23
2019 19
2020 14
2021 24
2022 26
2023 44
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

597 results

Results by year

Filters applied: . Clear all
Page 1
Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study.
Noller GE, Frampton CM, Yazar-Klosinski B. Noller GE, et al. Am J Drug Alcohol Abuse. 2018;44(1):37-46. doi: 10.1080/00952990.2017.1310218. Epub 2017 Apr 12. Am J Drug Alcohol Abuse. 2018. PMID: 28402682
The legal status of ibogaine in New Zealand provides a unique opportunity to evaluate durability of treatment outcomes. ...Ibogaine's legal availability in New Zealand may offer improved outcomes where legislation supports treatment providers to work closely …
The legal status of ibogaine in New Zealand provides a unique opportunity to evaluate durability of treatment outcomes. ...Ibogain …
Serotonin transporter-ibogaine complexes illuminate mechanisms of inhibition and transport.
Coleman JA, Yang D, Zhao Z, Wen PC, Yoshioka C, Tajkhorshid E, Gouaux E. Coleman JA, et al. Nature. 2019 May;569(7754):141-145. doi: 10.1038/s41586-019-1135-1. Epub 2019 Apr 24. Nature. 2019. PMID: 31019304 Free PMC article.
Here we report cryo-electron microscopy structures of SERT-ibogaine complexes captured in outward-open, occluded and inward-open conformations. Ibogaine binds to the central binding site, and closure of the extracellular gate largely involves movements of TMs 1b and …
Here we report cryo-electron microscopy structures of SERT-ibogaine complexes captured in outward-open, occluded and inward-open conf …
How toxic is ibogaine?
Litjens RP, Brunt TM. Litjens RP, et al. Clin Toxicol (Phila). 2016;54(4):297-302. doi: 10.3109/15563650.2016.1138226. Epub 2016 Jan 25. Clin Toxicol (Phila). 2016. PMID: 26807959 Review.
It is unlicensed but used in the treatment of drug and alcohol addiction. However, reports of ibogaine's toxicity are cause for concern. OBJECTIVES: To review ibogaine's pharmacokinetics and pharmacodynamics, mechanisms of action and reported toxicity. …
It is unlicensed but used in the treatment of drug and alcohol addiction. However, reports of ibogaine's toxicity are cause fo …
Ibogaine-associated cardiac arrest and death: case report and review of the literature.
Meisner JA, Wilcox SR, Richards JB. Meisner JA, et al. Ther Adv Psychopharmacol. 2016 Apr;6(2):95-8. doi: 10.1177/2045125315626073. Epub 2016 Jan 13. Ther Adv Psychopharmacol. 2016. PMID: 27141291 Free PMC article. Review.
We present the case report of a man whose use of ibogaine resulted in cardiac arrest and death, complemented by a review of the literature regarding ibogaine's clinical effects. ...His presentation was consistent with ibogaine-induced cardiotoxicity an …
We present the case report of a man whose use of ibogaine resulted in cardiac arrest and death, complemented by a review of the liter …
Ibogaine and addiction in the animal model, a systematic review and meta-analysis.
Belgers M, Leenaars M, Homberg JR, Ritskes-Hoitinga M, Schellekens AF, Hooijmans CR. Belgers M, et al. Transl Psychiatry. 2016 May 31;6(5):e826. doi: 10.1038/tp.2016.71. Transl Psychiatry. 2016. PMID: 27244235 Free PMC article. Review.
Although human clinical trials on the safety and efficacy of ibogaine are lacking, animal studies do support the efficacy of ibogaine. ...Ibogaine had no effect on drug-induced conditioned place preference. ...
Although human clinical trials on the safety and efficacy of ibogaine are lacking, animal studies do support the efficacy of iboga …
IUPHAR - invited review - Ibogaine - A legacy within the current renaissance of psychedelic therapy.
Mash DC. Mash DC. Pharmacol Res. 2023 Apr;190:106620. doi: 10.1016/j.phrs.2022.106620. Epub 2023 Mar 11. Pharmacol Res. 2023. PMID: 36907284 Free article. Review.
Ibogaine is a powerful psychoactive substance that not only alters perception, mood and affect, but also stops addictive behaviors. ...Ibogaine is rapidly demethylated by first-pass metabolism to a long-acting metabolite noribogaine. ...
Ibogaine is a powerful psychoactive substance that not only alters perception, mood and affect, but also stops addictive behaviors. . …
Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, Peyote, Ibogaine and Ayahuasca.
Winkelman M. Winkelman M. Curr Drug Abuse Rev. 2014;7(2):101-16. doi: 10.2174/1874473708666150107120011. Curr Drug Abuse Rev. 2014. PMID: 25563446 Review.
This paper reviews studies evaluating the use of LSD, peyote, ibogaine and ayahuasca in the treatment of dependencies and the possible mechanisms underlying the indications of effectiveness. ...
This paper reviews studies evaluating the use of LSD, peyote, ibogaine and ayahuasca in the treatment of dependencies and the possibl …
Ibogaine: a review.
Alper KR. Alper KR. Alkaloids Chem Biol. 2001;56:1-38. doi: 10.1016/s0099-9598(01)56005-8. Alkaloids Chem Biol. 2001. PMID: 11705103 Review. No abstract available.
Ibogaine in the treatment of substance dependence.
Brown TK. Brown TK. Curr Drug Abuse Rev. 2013 Mar;6(1):3-16. doi: 10.2174/15672050113109990001. Curr Drug Abuse Rev. 2013. PMID: 23627782 Review.
Largely because of ibogaine's status as a Schedule I substance in the U.S., the development of ibogaine's use in the treatment of drug addiction took place outside conventional clinical and medical settings. ...This article outlines major findings from …
Largely because of ibogaine's status as a Schedule I substance in the U.S., the development of ibogaine's use in …
597 results

Searches related to "ibogaine"